Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
暂无分享,去创建一个
Ming-Jing Hwang | Yun-Ching Chen | H. Shih | M. Hwang | G. Maul | Gerd G Maul | Che-Chang Chang | Yen-Sung Huang | Chun-Chen Ho | K. Chang | Ding-Yen Lin | Hong-Yi Kuo | Kun-Sang Chang | Ding-Yen Lin | Yen-Sung Huang | Jen-Chong Jeng | Hong-Yi Kuo | Che-Chang Chang | Ting-Ting Chao | Chun-Chen Ho | Tong-Ping Lin | Hsin-I Fang | Chih-Chang Hung | Ching-Shu Suen | Hsiu-Ming Shih | Yun-Ching Chen | Ching-Shu Suen | Ting-Ting Chao | Tong-Ping Lin | Hsin-I Fang | Jen‐Chong Jeng | Chi-Chang Hung
[1] E. Kieff,et al. NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[2] A. Sharrocks,et al. SUMO promotes HDAC-mediated transcriptional repression. , 2004, Molecular cell.
[3] R. Hay,et al. SUMO: a history of modification. , 2005, Molecular cell.
[4] David Owerbach,et al. A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. , 2005, Biochemical and biophysical research communications.
[5] G. Jenster,et al. Negative Modulation of Androgen Receptor Transcriptional Activity by Daxx , 2004, Molecular and Cellular Biology.
[6] Donghai Lin,et al. Identification of a Substrate Recognition Site on Ubc9* , 2002, The Journal of Biological Chemistry.
[7] J. Iñiguez-Lluhí,et al. A Small Conserved Surface in SUMO Is the Critical Structural Determinant of Its Transcriptional Inhibitory Properties , 2005, Molecular and Cellular Biology.
[8] M. Kaghad,et al. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. , 2000, The Journal of biological chemistry.
[9] Christopher D. Lima,et al. Structural Basis for E2-Mediated SUMO Conjugation Revealed by a Complex between Ubiquitin-Conjugating Enzyme Ubc9 and RanGAP1 , 2002, Cell.
[10] Paul Freemont,et al. Role of Promyelocytic Leukemia (Pml) Sumolation in Nuclear Body Formation, 11s Proteasome Recruitment, and as2O3-Induced Pml or Pml/Retinoic Acid Receptor α Degradation , 2001, The Journal of experimental medicine.
[11] K. Nakayama,et al. Noncovalent SUMO-1 Binding Activity of Thymine DNA Glycosylase (TDG) Is Required for Its SUMO-1 Modification and Colocalization with the Promyelocytic Leukemia Protein* , 2005, Journal of Biological Chemistry.
[12] G. Gill,et al. Something about SUMO inhibits transcription. , 2005, Current opinion in genetics & development.
[13] S. Weger,et al. The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation. , 2003, Experimental cell research.
[14] J. Iñiguez-Lluhí,et al. Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[15] Ailan Guo,et al. The function of PML in p53-dependent apoptosis , 2000, Nature Cell Biology.
[16] Ziming Zhang,et al. Small Ubiquitin-like Modifier (SUMO) Recognition of a SUMO Binding Motif , 2005, Journal of Biological Chemistry.
[17] G. Gill,et al. Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity. , 2003, Current opinion in genetics & development.
[18] Erica S. Johnson,et al. Protein modification by SUMO. , 2004, Annual review of biochemistry.
[19] P. Freemont,et al. PML protein isoforms and the RBCC/TRIM motif , 2001, Oncogene.
[20] T. A. Wilkinson,et al. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[21] H. de Thé,et al. Characterization of endogenous human promyelocytic leukemia isoforms. , 2006, Cancer research.
[22] H. Shih,et al. Essential Role of the 58-kDa Microspherule Protein in the Modulation of Daxx-dependent Transcriptional Repression as Revealed by Nucleolar Sequestration* , 2002, The Journal of Biological Chemistry.
[23] J. Iñiguez-Lluhí,et al. A Common Motif within the Negative Regulatory Regions of Multiple Factors Inhibits Their Transcriptional Synergy , 2000, Molecular and Cellular Biology.
[24] K. Yamamoto,et al. Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[25] S. Chae,et al. Interaction of Daxx, a Fas binding protein, with sentrin and Ubc9. , 2000, Biochemical and biophysical research communications.
[26] Fumio Hanaoka,et al. Crystal structure of thymine DNA glycosylase conjugated to SUMO-1 , 2005, Nature.
[27] O. Jänne,et al. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. , 2002, The Biochemical journal.
[28] H. Shih,et al. SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[29] Jinke Cheng,et al. Role of desumoylation in the development of prostate cancer. , 2006, Neoplasia.
[30] A. Dejean,et al. Conjugation with the ubiquitin‐related modifier SUMO‐1 regulates the partitioning of PML within the nucleus , 1998, The EMBO journal.
[31] David Reverter,et al. Insights into E3 ligase activity revealed by a SUMO–RanGAP1–Ubc9–Nup358 complex , 2005, Nature.
[32] S. Kogan,et al. A sumoylation site in PML/RARA is essential for leukemic transformation. , 2005, Cancer cell.
[33] Jennifer O'Neil,et al. Sequestration and Inhibition of Daxx-Mediated Transcriptional Repression by PML , 2000, Molecular and Cellular Biology.
[34] G. Maul,et al. Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX , 2004, Journal of Cell Science.
[35] Ming-Zong Lai,et al. Promyelocytic Leukemia Protein (PML) Functions as a Glucocorticoid Receptor Co-activator by Sequestering Daxx to the PML Oncogenic Domains (PODs) to Enhance Its Transactivation Potential* , 2003, The Journal of Biological Chemistry.
[36] P. Pandolfi,et al. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML , 2001, Oncogene.
[37] H. Shih,et al. Daxx Mediates the Small Ubiquitin-like Modifier-dependent Transcriptional Repression of Smad4* , 2005, Journal of Biological Chemistry.
[38] E. Yeh,et al. Pml Is Critical for Nd10 Formation and Recruits the Pml-Interacting Protein Daxx to This Nuclear Structure When Modified by Sumo-1 , 1999, The Journal of cell biology.
[39] P. Pandolfi,et al. Role of SUMO-1-modified PML in nuclear body formation. , 2000, Blood.
[40] N. Perkins,et al. P300 transcriptional repression is mediated by SUMO modification. , 2003, Molecular cell.
[41] Min Wang,et al. The Small Ubiquitin-like Modifier-1 (SUMO-1) Consensus Sequence Mediates Ubc9 Binding and Is Essential for SUMO-1 Modification* , 2001, The Journal of Biological Chemistry.
[42] F. Melchior,et al. SUMO: ligases, isopeptidases and nuclear pores. , 2003, Trends in biochemical sciences.
[43] G. Hayward,et al. Evaluation of Interactions of Human Cytomegalovirus Immediate-Early IE2 Regulatory Protein with Small Ubiquitin-Like Modifiers and Their Conjugation Enzyme Ubc9 , 2001, Journal of Virology.
[44] Eunhee Kim,et al. Modification of Daxx by small ubiquitin-related modifier-1. , 2002, Biochemical and biophysical research communications.